How many CLL patients are there in China?

Update Date: Source: Network

summary

Chronic lymphoblastic leukemia is the abbreviation of chronic lymphoblastic leukemia. This disease is caused by malignant clonal proliferation of B lymphocytes in the body. Sometimes it can be manifested as clonal proliferation of T lymphocytes, but it is rare. This disease generally does not make people feel pain, the speed of onset is relatively slow, after the onset, there will be a lot of small lymphocytes constantly accumulated in the body, so that patients appear lymphocyte immune dysfunction, the stimulating response to some antigens become slow. Patients will be accompanied by varying degrees of immune dysfunction. Let's take a look at the following.

How many CLL patients are there in China?

First: chronic lymphoblastic leukemia in a period of time is generally do not need treatment, but this period of chronic lymphoblastic leukemia need to do regular physical examination, the purpose is to avoid the development of the disease or early detection of disease development and treatment. Generally, a stage of chronic lymphoblastic leukemia can develop to B and C stage

Second: chronic lymphoblastic leukemia can be treated by combined chemotherapy, the so-called combined chemotherapy is worth a variety of chemotherapy drugs at the same time. Prednisone and pdn10 are commonly used in combination chemotherapy of chronic lymphoblastic leukemia. The two drugs were combined with chemotherapy for four consecutive days, followed by chemotherapy every three weeks.

Third: the treatment of chronic lymphoblastic leukemia can make chemotherapy, the use of phenylbutyric acid nitrogen mustard drugs, this drug is also widely used in chemotherapy of chronic lymphoblastic leukemia drug clock, the usage is continuous oral about 12 days, and then reduce the dosage, but after a long period of maintenance medication

matters needing attention

In addition to chemotherapy, chronic lymphoblastic leukemia can also be treated by radiotherapy. Radiotherapy is mainly for some superficial or deep lymph node enlargement or chronic lymphoblastic leukemia with splenomegaly, but the effect of radiotherapy is not significant.